Trial · NCT00838903
Results by group52
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 52
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Change From Baseline (BL) in Glycosylated Hemoglobin (HbA1c) at Week 104 | Placebo Plus Metformin | 0.27 | Standard Error 0.113 | Percentage of HbA1c in the blood | |
| Change From Baseline (BL) in Glycosylated Hemoglobin (HbA1c) at Week 104 | Sitagliptin 100 mg Plus Metformin | -0.28 | Standard Error 0.065 | Percentage of HbA1c in the blood | |
| Change From Baseline (BL) in Glycosylated Hemoglobin (HbA1c) at Week 104 | Glimepiride 2 mg Plus Metformin | -0.36 | Standard Error 0.064 | Percentage of HbA1c in the blood | |
| Change From Baseline (BL) in Glycosylated Hemoglobin (HbA1c) at Week 104 | Albiglutide 30 mg Plus Metformin | -0.63 | Standard Error 0.065 | Percentage of HbA1c in the blood | |
| Change From Baseline in HbA1c at Week 156 | Placebo Plus Metformin | -0.46 | Standard Deviation 0.820 | Percentage of HbA1c in the blood | |
| Change From Baseline in HbA1c at Week 156 | Sitagliptin 100 mg Plus Metformin | -0.56 | Standard Deviation 1.160 | Percentage of HbA1c in the blood | |
| Change From Baseline in HbA1c at Week 156 | Glimepiride 2 mg Plus Metformin | -0.59 | Standard Deviation 0.999 | Percentage of HbA1c in the blood | |
| Change From Baseline in HbA1c at Week 156 | Albiglutide 30 mg Plus Metformin | -0.88 | Standard Deviation 0.959 | Percentage of HbA1c in the blood | |
| Change From Baseline in Fasting Plasma Glucose (FPG) at Week 104 | Placebo Plus Metformin | 0.55 | Standard Error 0.277 | Millimoles per liter (mmol/L) | |
| Change From Baseline in Fasting Plasma Glucose (FPG) at Week 104 | Sitagliptin 100 mg Plus Metformin | -0.12 | Standard Error 0.160 | Millimoles per liter (mmol/L) | |
| Change From Baseline in Fasting Plasma Glucose (FPG) at Week 104 | Glimepiride 2 mg Plus Metformin | -0.41 | Standard Error 0.159 | Millimoles per liter (mmol/L) | |
| Change From Baseline in Fasting Plasma Glucose (FPG) at Week 104 | Albiglutide 30 mg Plus Metformin | -0.98 | Standard Error 0.161 | Millimoles per liter (mmol/L) | |
| Change From Baseline in FPG at Week 156 | Placebo Plus Metformin | -0.11 | Standard Deviation 1.498 | Millimoles per liter (mmol/L) | |
| Change From Baseline in FPG at Week 156 | Sitagliptin 100 mg Plus Metformin | -0.50 | Standard Deviation 2.519 | Millimoles per liter (mmol/L) | |
| Change From Baseline in FPG at Week 156 | Glimepiride 2 mg Plus Metformin | -0.71 | Standard Deviation 2.684 | Millimoles per liter (mmol/L) | |
| Change From Baseline in FPG at Week 156 | Albiglutide 30 mg Plus Metformin | -1.30 | Standard Deviation 2.602 | Millimoles per liter (mmol/L) | |
| Number of Participants Who Achieved Clinically Meaningful HbA1c Response Levels of <6.5%, <7%, and <7.5% at Week 104 | Placebo Plus Metformin | HbA1c <6.5% | 7 | Participants | |
| Number of Participants Who Achieved Clinically Meaningful HbA1c Response Levels of <6.5%, <7%, and <7.5% at Week 104 | Sitagliptin 100 mg Plus Metformin | HbA1c <6.5% | 45 | Participants | |
| Number of Participants Who Achieved Clinically Meaningful HbA1c Response Levels of <6.5%, <7%, and <7.5% at Week 104 | Glimepiride 2 mg Plus Metformin | HbA1c <6.5% | 40 | Participants | |
| Number of Participants Who Achieved Clinically Meaningful HbA1c Response Levels of <6.5%, <7%, and <7.5% at Week 104 | Albiglutide 30 mg Plus Metformin | HbA1c <6.5% | 50 | Participants |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00838903/results